Industry in brief | Royal DSM, Flarin
6 April 2021
Royal DSM is investing USD100 million in a new personalised nutrition company called Hologram Sciences and Flarin has completed a second fundraising round.
Industry News
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
PharmaSGP remains keen to acquire brands
Premium
6 April 2021
German consumer healthcare company PharmaSGP said it was still seeking acquisitions as it reported sales up by 1.1% to EUR63.2 million (USD74.9 million) in 2020.
Dermapharm reports sales up by 13% in 2020
Premium
6 April 2021
German pharmaceutical company Dermapharm reported sales up by 13% to EUR794 million (USD945 million) in 2020.
Takeda Consumer Healthcare becomes Alinamin
Premium
31 March 2021
Takeda Consumer Healthcare Company (TCHC) is now operating as Alinamin Pharmaceutical Co following completion of the divestment to private-equity firm Blackstone.
Probi partners with Sinopharm in China
Premium
30 March 2021
Swedish probiotic specialist Probi and China’s Sinopharm have entered into a strategic partnership for the Chinese market.
Enzymatica issues warning and plans fundraising
Premium
29 March 2021
Enzymatica has warned that sales of its ColdZyme common cold spray may be lower in 2021 than in 2020 due to the impact of the COVID-19 pandemic.
Regulatory in brief | Norway, US, New Zealand
29 March 2021
The Norwegian Medicines Agency (NoMA) is postponing some non-prescription medicines work due to the COVID-19 pandemic, the US has a new secretary of the Department of Health & Human Services (HHS), and New Zealand’s Medsafe has announced changes affecting medicines containing paracetamol.
GL Capital to acquire HutchMed’s OTC venture
Premium
26 March 2021
Private-equity firm GL Capital is acquiring Hutchison China MediTech’s (HutchMed’s) holding in its non-core OTC joint venture Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company (HBYS).
Germany to consider three OTC switch applications
Premium
26 March 2021
Three applications to switch medicines from prescription to non-prescription status are on the agenda in Germany.
Reckitt Benckiser rebrands itself as Reckitt
26 March 2021
Reckitt Benckiser (RB) has rebranded itself as Reckitt.